Perimenopause Testing

The appointment starts with the changes you have noticed. A clinician asks when periods became different, whether you have hot flashes or night sweats, and how sleep, mood, and vaginal comfort have changed. They also review contraception, medications, pregnancy possibility, and any surgery or treatment affecting the ovaries.

For an otherwise healthy person aged 45 or older with recently started hot flashes or night sweats and a changing menstrual cycle, NICE recommends identifying perimenopause without routine laboratory tests. In that situation, the combination of age and symptoms gives more useful information than a hormone level taken on one day.

An assessment can still include tests for a particular symptom. Heavy bleeding, for example, may require a blood count and evaluation of the uterus. Fatigue accompanied by cold intolerance or other thyroid symptoms may lead to thyroid testing. These tests investigate causes that can coexist with perimenopause.

Follicle-stimulating hormone, or FSH, is produced by the pituitary gland and helps regulate ovarian activity. FSH tends to rise as ovarian function declines. During perimenopause, however, it can fluctuate considerably alongside estrogen and ovulation.

A high FSH result can be consistent with declining ovarian function. A lower result on another day can also occur during the same transition. The STRAW+10 staging guidance describes this variability, especially during the late transition when periods become more widely spaced.

For that reason, a result needs to be interpreted with your age, menstrual history, symptoms, and medication use. A single value has limited ability to establish the stage, estimate the date of the final period, or determine whether contraception can safely stop.

When an FSH test may help

NICE advises considering FSH testing between ages 40 and 45 when menopause symptoms include a changing cycle, and before 40 when ovarian insufficiency is suspected. Symptoms at younger ages have different implications for fertility, bone health, and the duration of hormone treatment.

If premature ovarian insufficiency is being investigated, the clinician may need repeat measurements and specialist input. NICE specifies elevated FSH on two samples four to six weeks apart for its diagnostic approach. Ask which guideline and follow-up plan apply to your situation.

A pelvic ultrasound can investigate bleeding, but ovarian volume and follicle counts are not recommended by NICE as routine tests to identify perimenopause in people aged 45 or older. Explain the question you want answered before buying a test or arranging a scan.

Estradiol is a form of estrogen made by the ovaries. Its level changes during a menstrual cycle and can fluctuate widely during perimenopause. A result needs clinical context, including when it was taken and whether you are using hormones.

Anti-Müllerian hormone, or AMH, relates to ovarian follicle activity and is used in some fertility assessments. It cannot give a dependable personal countdown to menopause. NICE recommends against using AMH or estradiol to identify perimenopause or menopause routinely in people aged 45 or older.

If you are having a fertility evaluation, these tests may have a separate purpose. Ask the fertility specialist how the result affects treatment decisions, and discuss menopause symptoms with the clinician managing those symptoms.

Combined hormonal contraception changes ovarian hormone activity and bleeding. A hormonal IUD, implant, or injection can also make periods lighter, irregular, or absent. The usual 12-month period rule may therefore be difficult to apply while using hormonal treatment.

NICE advises against using FSH to identify menopause while someone is taking combined estrogen and progestogen contraception or high-dose progestogen. Other methods require their own approach to interpretation and advice about when contraception can stop.

If a home kit measures FSH, it faces the same variability as a laboratory FSH measurement. A result can show the level at the time of testing, but needs interpretation alongside symptoms and medications. Bring the result and the kit name to a clinician if you have already used one.

• Bring period dates, a description of the flow, and the dates your main symptoms began.
• List contraception, prescribed medication, supplements, and any recent dose changes.
• Ask what each proposed test is investigating and what happens after the result.
• Explain the symptoms you want treated now, including sleep disruption, heat episodes, or pain with sex.

A normal thyroid result or blood count answers that particular question. It may leave menopause symptoms as the likely explanation, or lead to a different assessment. Review results with the clinician who ordered them so the next step follows the full history.

You can discuss symptom treatment before a final menopause date is known. An assessment is particularly important for symptoms before 45, very heavy bleeding, or any bleeding after 12 months without a natural period.